Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 2
2006 1
2007 1
2009 2
2012 1
2013 1
2015 1
2016 1
2017 2
2019 1
2020 3
2021 3
2022 6
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Results by year

Filters applied: . Clear all
Page 1
Exosome: A New Player in Translational Nanomedicine.
Aheget H, Tristán-Manzano M, Mazini L, Cortijo-Gutierrez M, Galindo-Moreno P, Herrera C, Martin F, Marchal JA, Benabdellah K. Aheget H, et al. Among authors: herrera c. J Clin Med. 2020 Jul 26;9(8):2380. doi: 10.3390/jcm9082380. J Clin Med. 2020. PMID: 32722531 Free PMC article. Review.
Genome-edited adult stem cells: Next-generation advanced therapy medicinal products.
Benabdellah K, Sánchez-Hernández S, Aguilar-González A, Maldonado-Pérez N, Gutierrez-Guerrero A, Cortijo-Gutierrez M, Ramos-Hernández I, Tristán-Manzano M, Galindo-Moreno P, Herrera C, Martin F. Benabdellah K, et al. Among authors: herrera c. Stem Cells Transl Med. 2020 Jun;9(6):674-685. doi: 10.1002/sctm.19-0338. Epub 2020 Mar 6. Stem Cells Transl Med. 2020. PMID: 32141715 Free PMC article. Review.
Using Gene Editing Approaches to Fine-Tune the Immune System.
Pavlovic K, Tristán-Manzano M, Maldonado-Pérez N, Cortijo-Gutierrez M, Sánchez-Hernández S, Justicia-Lirio P, Carmona MD, Herrera C, Martin F, Benabdellah K. Pavlovic K, et al. Among authors: herrera c. Front Immunol. 2020 Sep 29;11:570672. doi: 10.3389/fimmu.2020.570672. eCollection 2020. Front Immunol. 2020. PMID: 33117361 Free PMC article. Review.
Efficacy and safety of universal (TCRKO) ARI-0001 CAR-T cells for the treatment of B-cell lymphoma.
Maldonado-Pérez N, Tristán-Manzano M, Justicia-Lirio P, Martínez-Planes E, Muñoz P, Pavlovic K, Cortijo-Gutiérrez M, Blanco-Benítez C, Castella M, Juan M, Wenes M, Romero P, Molina-Estévez FJ, Marañón C, Herrera C, Benabdellah K, Martin F. Maldonado-Pérez N, et al. Among authors: herrera c. Front Immunol. 2022 Oct 6;13:1011858. doi: 10.3389/fimmu.2022.1011858. eCollection 2022. Front Immunol. 2022. PMID: 36275777 Free PMC article.
ECP versus ruxolitinib in steroid-refractory acute GVHD - a retrospective study by the EBMT transplant complications working party.
Penack O, Peczynski C, Boreland W, Lemaitre J, Afanasyeva K, Kornblit B, Jurado M, Martinez C, Natale A, Pérez-Simón JA, Brunello L, Avenoso D, Klein S, Ozkurt ZN, Herrera C, Wichert S, Chiusolo P, Gavriilaki E, Basak GW, Schoemans H, Koenecke C, Moiseev I, Peric Z. Penack O, et al. Among authors: herrera c. Front Immunol. 2023 Dec 11;14:1283034. doi: 10.3389/fimmu.2023.1283034. eCollection 2023. Front Immunol. 2023. PMID: 38149251 Free PMC article.
Safety and efficacy of intra-arterial bone marrow mononuclear cell transplantation in patients with acute ischaemic stroke in Spain (IBIS trial): a phase 2, randomised, open-label, standard-of-care controlled, multicentre trial.
Moniche F, Cabezas-Rodriguez JA, Valverde R, Escudero-Martinez I, Lebrato-Hernandez L, Pardo-Galiana B, Ainz L, Medina-Rodriguez M, de la Torre J, Escamilla-Gomez V, Ortega-Quintanilla J, Zapata-Arriaza E, de Albóniga-Chindurza A, Mancha F, Gamero MA, Perez S, Espinosa-Rosso R, Forero-Diaz L, Moya M, Piñero P, Calderón-Cabrera C, Nogueras S, Jimenez R, Martin V, Delgado F, Ochoa-Sepúlveda JJ, Quijano B, Mata R, Santos-González M, Carmona-Sanchez G, Herrera C, Gonzalez A, Montaner J. Moniche F, et al. Among authors: herrera c. Lancet Neurol. 2023 Feb;22(2):137-146. doi: 10.1016/S1474-4422(22)00526-9. Lancet Neurol. 2023. PMID: 36681446 Clinical Trial.
Physiological lentiviral vectors for the generation of improved CAR-T cells.
Tristán-Manzano M, Maldonado-Pérez N, Justicia-Lirio P, Muñoz P, Cortijo-Gutiérrez M, Pavlovic K, Jiménez-Moreno R, Nogueras S, Carmona MD, Sánchez-Hernández S, Aguilar-González A, Castella M, Juan M, Marañón C, Marchal JA, Benabdellah K, Herrera C, Martin F. Tristán-Manzano M, et al. Among authors: herrera c. Mol Ther Oncolytics. 2022 May 18;25:335-349. doi: 10.1016/j.omto.2022.05.003. eCollection 2022 Jun 16. Mol Ther Oncolytics. 2022. PMID: 35694446 Free PMC article.
28 results